Fospropofol methods and compositions
US11628178B2 · kind B2 · utility
3Cited by
20References
32Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 4, 2022 |
| Grant date | Apr 18, 2023 |
| Priority date | — |
| Expiry date | Mar 4, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure pertains to the use of fospropofol, pharmaceutically acceptable salts of fospropofol, or mixtures thereof. Pharmaceutical compositions comprising fospropofol, pharmaceutically acceptable salts of fospropofol, or mixtures thereof, and methods of treating diseases or disorders, including migraine are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.